Oropharyngeal Squamous Cell Carcinoma Morphology and Subtypes by Human Papillomavirus Type and by 16 Lineages and Sublineages.


Journal

Head and neck pathology
ISSN: 1936-0568
Titre abrégé: Head Neck Pathol
Pays: United States
ID NLM: 101304010

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 14 02 2021
accepted: 19 03 2021
pubmed: 3 4 2021
medline: 23 3 2022
entrez: 2 4 2021
Statut: ppublish

Résumé

Oropharyngeal squamous cell carcinoma (SCC) is increasing in incidence and, in Western countries, strongly associated with transcriptionally-active high-risk human papillomavirus (HPV). Within HPV-positive tumors, there is wide morphologic diversity with numerous histologic subtypes of SCC. There are also variable degrees of keratinization, anaplasia, stromal fibrosis, and maturing squamous differentiation. Unlike in the uterine cervix, where associations between HPV types and lineages/sublineages within types have been investigated with some clear correlations identified, little to no data exists for oropharyngeal SCC. In this study, for a large cohort of oropharyngeal SCC patients, we performed RTPCR for high-risk HPV. For the HPV positive patients, we sequenced the DNA of the entire HPV16 genome and determined lineages and sublineages, correlating HPV status, genotype, and HPV16 lineages/sublineages with SCC subtype and various histologic features. Of the 259 patients, 224 (86.5%) were high-risk HPV positive, of which 210/224 (93.8%) were HPV type 16 and 6/224 (2.7%) HPV type 33. Of the four HPV16 lineages, A was the most frequent (192/214 or 89.8%) and of the HPV16 A sublineages, A1 was the most frequent (112/210 or 53.3%). Patients with HPV negative tumors were more often keratinizing vs other types (23/35 or 65.7%) and thus more likely to have more maturing squamous differentiation and stromal desmoplasia. There was no significant correlation between HPV type (16 versus other), between HPV16 lineage (A versus others), or HPV16 A sublineages (A1 or A2 versus others) and morphologic type of SCC nor the various morphologic features of anaplasia/multinucleation, degree of keratinization, nor amount of stromal desmoplasia. In summary, in our cohort, there was no correlation between the type of HPV, the HPV 16 lineage or sublineage, and any of the histologic features or morphologic SCC subtypes.

Identifiants

pubmed: 33797697
doi: 10.1007/s12105-021-01318-4
pii: 10.1007/s12105-021-01318-4
pmc: PMC8633182
doi:

Substances chimiques

RNA, Messenger 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1089-1098

Subventions

Organisme : NIDCR NIH HHS
ID : R01 DE026471
Pays : United States
Organisme : NCI NIH HHS
ID : 5P30 CA68485-19
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA068485
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK059637
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA218247
Pays : United States
Organisme : NIH HHS
ID : R01DE026471
Pays : United States

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Int J Cancer. 2013 Feb 15;132(4):882-90
pubmed: 22821242
J Biomed Inform. 2014 Dec;52:28-35
pubmed: 24534443
Am J Surg Pathol. 2016 Aug;40(8):1117-24
pubmed: 27035614
J Clin Oncol. 2015 Oct 10;33(29):3235-42
pubmed: 26351338
J Natl Cancer Inst. 2000 May 3;92(9):709-20
pubmed: 10793107
Virology. 2013 Oct;445(1-2):232-43
pubmed: 23998342
Br J Cancer. 2003 Jan 13;88(1):63-73
pubmed: 12556961
Am J Surg Pathol. 2010 Jun;34(6):800-5
pubmed: 20421782
Histopathology. 2012 Feb;60(3):427-36
pubmed: 22211374
Viruses. 2018 Feb 13;10(2):
pubmed: 29438321
Head Neck Pathol. 2009 Sep;3(3):186-94
pubmed: 20596971
Head Neck Pathol. 2012 Jul;6 Suppl 1:S41-7
pubmed: 22782222
Cancer Epidemiol Biomarkers Prev. 2008 Jul;17(7):1611-22
pubmed: 18628412
Eur J Cancer. 2015 Apr;51(6):776-85
pubmed: 25702585
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Am J Surg Pathol. 2012 Jul;36(7):1036-46
pubmed: 22743286
Papillomavirus Res. 2015 Dec 1;1:3-11
pubmed: 26645052
J Natl Cancer Inst. 2008 Feb 20;100(4):261-9
pubmed: 18270337
J Natl Cancer Inst. 2016 Apr 29;108(9):
pubmed: 27130930
J Med Virol. 2011 Jun;83(6):1034-41
pubmed: 21503917
Am J Surg Pathol. 2012 Jul;36(7):945-54
pubmed: 22743284
Bioinformatics. 2006 Nov 1;22(21):2688-90
pubmed: 16928733

Auteurs

James S Lewis (JS)

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Vanderbilt University Hospital, Room 3020D 1121 Medical Center Drive, Nashville, TN, 37232-2561, USA. james.lewis@vumc.org.
Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA. james.lewis@vumc.org.

Lisa Mirabello (L)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Ping Liu (P)

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.

Xiaowei Wang (X)

Department of Pharmacology and Regenerative Medicine, The University of Illinois at Chicago, Chicago, IL, USA.

William D Dupont (WD)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

W Dale Plummer (WD)

Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

Maisa Pinheiro (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Meredith Yeager (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc, Frederick, MD, USA.

Joseph F Boland (JF)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc, Frederick, MD, USA.

Michael Cullen (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc, Frederick, MD, USA.

Mia Steinberg (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc, Frederick, MD, USA.

Sara Bass (S)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
Cancer Genomics Research Laboratory, Leidos Biomedical Research, Inc, Frederick, MD, USA.

Mitra Mehrad (M)

Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Vanderbilt University Hospital, Room 3020D 1121 Medical Center Drive, Nashville, TN, 37232-2561, USA.

Connor O'Boyle (C)

Department of Otolaryngology, Head and Neck Surgical Oncology, Massachusetts Eye and Ear, Boston, MA, USA.

Maoxuan Lin (M)

Department of Otolaryngology, Head and Neck Surgical Oncology, Massachusetts Eye and Ear, Boston, MA, USA.

Daniel L Faden (DL)

Department of Otolaryngology, Head and Neck Surgical Oncology, Massachusetts Eye and Ear, Boston, MA, USA.
Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Krystle A Lang-Kuhs (KA)

Department of Otolaryngology - Head and Neck Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Department of Epidemiology, University of Kentucky College of Public Health, Lexington, KY, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH